Impact of social and clinical factors on the diagnostic delay of chronic kidney disease: an evaluation study
- PMID: 34713367
- DOI: 10.1007/s11255-021-03037-9
Impact of social and clinical factors on the diagnostic delay of chronic kidney disease: an evaluation study
Abstract
Aim: This study aimed to investigate the impact of social and clinical factors on the diagnostic delay of chronic kidney disease (CKD) among Iranian patients.
Materials and methods: Our study was conducted on 350 CKD patients who were referred to Faghihi and Motahari clinics (the two largest kidney diseases referral centers in Shiraz the capital of Fars province). Data were collected via an interviewer-administered questionnaire. A multiple linear regression model was used to measure the effect of factors affecting the delay of CKD diagnosis.
Results: The medians and Interquartile ranges (IQR) of all delays, patient delay, and doctor delay were 6.5 (0-12.2), 5.1 (0-11.2), and 0.9 (0-3.1) months, respectively. The results showed that women were diagnosed 1.61 months earlier than men (p < 0.05). The duration of all delays in patients residing in the rural areas was 1.28 months longer than patients residing in the urban areas (p < 0.05). Also, patients with perceived good economic status were diagnosed 1.30 months earlier than patients who reported having very poor economic status (p < 0.05).
Conclusions: The delay is in part due to the neglect and misinterpretation of symptoms by both patients and physicians. It is necessary to improve the awareness of CKD among general public and medical professionals.
Keywords: Chronic kidney disease; Diagnosis delay; Related factors.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Impact of social and clinical factors on diagnostic delay of breast cancer: A Cross-sectional Study.Medicine (Baltimore). 2016 Sep;95(38):e4704. doi: 10.1097/MD.0000000000004704. Medicine (Baltimore). 2016. PMID: 27661018 Free PMC article.
-
Multiple sclerosis diagnosis delay and its associated factors among Iranian patients.Clin Neurol Neurosurg. 2020 Dec;199:106278. doi: 10.1016/j.clineuro.2020.106278. Epub 2020 Oct 4. Clin Neurol Neurosurg. 2020. PMID: 33069931
-
Time to first consultation, diagnosis and treatment of TB among patients attending a referral hospital in Northwest, Ethiopia.BMC Infect Dis. 2014 Jan 10;14:19. doi: 10.1186/1471-2334-14-19. BMC Infect Dis. 2014. PMID: 24410927 Free PMC article.
-
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210. Health Technol Assess. 2010. PMID: 20441712 Review.
-
Chronic kidney disease: importance of early diagnosis, immediate referral and structured interdisciplinary approach to improve outcomes in patients not yet on dialysis.J Bras Nefrol. 2011 Mar;33(1):93-108. J Bras Nefrol. 2011. PMID: 21541469 Review. English, Portuguese.
Cited by
-
The global survival rate of graft and patient in kidney transplantation of children: a systematic review and meta-analysis.BMC Pediatr. 2022 Aug 24;22(1):503. doi: 10.1186/s12887-022-03545-2. BMC Pediatr. 2022. PMID: 36002803 Free PMC article.
-
An exploration of under-registration of chronic kidney disease stages 3-5 in Belgian general practices using logistic regression.PLoS One. 2022 Dec 22;17(12):e0279291. doi: 10.1371/journal.pone.0279291. eCollection 2022. PLoS One. 2022. PMID: 36548280 Free PMC article.
-
Patient delay in chronic kidney disease: A qualitative study.Medicine (Baltimore). 2023 Dec 1;102(48):e36428. doi: 10.1097/MD.0000000000036428. Medicine (Baltimore). 2023. PMID: 38050199 Free PMC article.
References
-
- Ghelichi Ghojogh M, Salarilak S, Taghezadeh Afshari A et al (2017) The effect of body mass index on patient and graft survival rate in kidney transplanted patients in Iran. Nephrourol Mon 9(4):1–6. https://doi.org/10.5812/numonthly.14386 - DOI
-
- Kimura K, Hosoya T, Uchida S et al (2018) Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72(6):798–810. https://doi.org/10.1053/j.ajkd.2018.06.028 - DOI - PubMed
-
- Foster MC, Hwang S-J, Larson MG et al (2008) Overweight, obesity, and the development of stage 3 CKD: the Framingham heart study. Am J Kidney Dis 52(1):39–48. https://doi.org/10.1053/j.ajkd.2008.03.003 - DOI - PubMed - PMC
-
- El Nahas AM, Bello AK (2005) Chronic kidney disease: the global challenge. The Lancet 365(9456):331–340. https://doi.org/10.1016/S0140-6736(05)17789-7 - DOI
-
- Marie Patrice H, Joiven N, Hermine F (2019) Factors associated with late presentation of patients with chronic kidney disease in nephrology consultation in Cameroon-a descriptive cross-sectional study. Ren Fail 41(1):384–392. https://doi.org/10.1080/0886022x.2019.1595644 - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical